Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX 78249, USA.
Microb Pathog. 2011 Dec;51(6):432-41. doi: 10.1016/j.micpath.2011.08.003. Epub 2011 Aug 29.
Production of reactive oxygen species (ROS) resulting from phagocytic NADPH oxidase (NOX2) activity has been reported to contribute to host defense against numerous microbial pathogens. In this study we explored the role of NOX2 production in experimental coccidioidomycosis, a human respiratory disease caused by a soil-borne fungal pathogen. Activated and non-activated macrophages isolated from either NOX2(-/-) knock-out or wild type (WT) mice showed comparable ROS production and killing efficiency in vitro when infected with parasitic cells of Coccidioides. Both mouse strains also revealed similar fungal burden in their lungs and spleen at 7 and 11 days after intranasal challenge with Coccidioides spores, although the NOX2(-/-) mice died earlier than the WT strain. Immunization of the NOX2(-/-) and WT mice with a live, attenuated vaccine strain of Coccidioides also resulted in comparable reduction of the fungal burden in both lungs and spleen. These combined results initially suggested that NOX2 activity and ROS production are not essential for protection against Coccidioides infection. However, the reduced survival of non-vaccinated NOX2(-/-) mice correlated with high, sustained numbers of lung-infiltrated neutrophils on days 7 and 11 postchallenge, an expansion of the regulatory T cell population in infected lungs in the knock-out mice, and elevated concentrations of pro-inflammatory cytokines and chemokines in lung homogenates compared to infected WT mice. Although NOX2-derived ROS appeared to be dispensable for both innate and acquired immunity to pulmonary Coccidioides infection, evidence is presented that NOX2 production plays a role in limiting pathogenic inflammation in this murine model of coccidioidomycosis.
吞噬细胞 NADPH 氧化酶(NOX2)活性产生的活性氧(ROS)已被报道有助于宿主防御许多微生物病原体。在这项研究中,我们探讨了 NOX2 产生在实验性球孢子菌病(一种由土壤传播的真菌病原体引起的人类呼吸道疾病)中的作用。从 NOX2(-/-)敲除或野生型(WT)小鼠中分离出的激活和未激活的巨噬细胞在感染球孢子菌的寄生细胞时,在体外显示出相当的 ROS 产生和杀伤效率。在鼻腔内用球孢子菌孢子攻击后 7 天和 11 天,两种小鼠品系的肺部和脾脏中的真菌负荷也相似,尽管 NOX2(-/-)小鼠比 WT 株更早死亡。用活的、减毒的球孢子菌疫苗株对 NOX2(-/-)和 WT 小鼠进行免疫接种,也导致肺部和脾脏中的真菌负荷均有相当程度的减少。这些综合结果最初表明,NOX2 活性和 ROS 产生对于抵抗球孢子菌感染不是必需的。然而,未接种疫苗的 NOX2(-/-)小鼠的存活率降低与感染后第 7 天和第 11 天肺部浸润的中性粒细胞数量高且持续增加、敲除小鼠感染肺部调节性 T 细胞群体的扩张以及肺部匀浆中促炎细胞因子和趋化因子浓度升高相关。尽管 NOX2 衍生的 ROS 似乎对肺部球孢子菌感染的固有和获得性免疫都不是必需的,但有证据表明,NOX2 产生在限制这种球孢子菌病的小鼠模型中的致病性炎症中发挥作用。